Investigator-initiated phase 2 trial to expand clinical evaluation of GKT831 into additional fibrotic disorder

Image: Genkyotex announces phase 2 trial for GKT831 in idiopathic pulmonary fibrosis. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.